Pricing Log in Create free account

Viking Therapeutics, Inc. (VKTX) vs Xenon Pharmaceuticals Inc. (XENE)

Viking Therapeutics, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Xenon Pharmaceuticals Inc. is the larger, with a market value of $3.7B against $3.3B — 1.1× the size. Across the 11 metrics below, Xenon Pharmaceuticals Inc. leads on 10 and Viking Therapeutics, Inc. on 1.

Valuation

Metric VKTX XENE Biotechnology median
P/E n/m n/m 10.60
P/S n/m 229.41 9.40
P/B 5.38 3.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 176.02 9.02
Earnings yield (20.14%) (12.15%) (32.88%)
Free cash flow yield (14.61%) (8.71%) (23.13%)

Profitability

Metric VKTX XENE Biotechnology median
Gross margin 0.00% 28.40% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (96.37%) (43.62%) (51.96%)
Return on assets (73.07%) (41.54%) (46.06%)
Return on invested capital 0.00% (88.54%) 0.00%

Growth

Metric VKTX XENE Biotechnology median
Revenue growth (TTM) — (8.15%) 6.76%
EPS growth (last fiscal year) (215.84%) (44.85%) 29.88%
Revenue growth, 5-year CAGR — 89.00% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VKTX XENE Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 7.27 21.02 4.97
Net debt to EBITDA 1.76 1.48 1.01

Dividend

Metric VKTX XENE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VKTX XENE Biotechnology median
Market cap 3.29b 3.65b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack